Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508‐CFTR for cystic fibrosis
Abstract Rare diseases affect 10% of the first‐world population, yet over 95% lack even a single pharmaceutical treatment. In the present age of information, we need ways to leverage our vast data and knowledge to streamline therapeutic development and lessen this gap. Here, we develop and implement...
Saved in:
Main Authors: | Rachel A. Hodos (Author), Matthew D. Strub (Author), Shyam Ramachandran (Author), Ella A. Meleshkevitch (Author), Dmitri Y. Boudko (Author), Robert J. Bridges (Author), Joel T. Dudley (Author), Paul B. McCray Jr (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of multiple gene co-expression networks to discover interactions favoring CFTR biogenesis and ΔF508-CFTR rescue
by: Matthew D. Strub, et al.
Published: (2021) -
Translating in vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network‐based Cellular Signatures drug discovery platform
by: Matthew D. Strub, et al.
Published: (2022) -
Functional rescue of F508del-CFTR using small molecule correctors
by: Steven eMolinski, et al.
Published: (2012) -
Decreasing Poly(ADP-ribose) Polymerase activity restores ΔF508 CFTR trafficking
by: Suzana Maria Anjos, et al.
Published: (2012) -
Differential Effects of Oleuropein and Hydroxytyrosol on Aggregation and Stability of CFTR NBD1-ΔF508 Domain
by: Christopher S. Robinson, et al.
Published: (2021)